Methylprednisolone/methylprednisolone-sodium-succinate/prednisone

In a case series, 5 patients (1 man and 4 women) were described, who developed osteoporosis and associated complications following treatment with methylprednisolone [Medrol], methylprednisolone-sodium-succinate [Solumedrol] or prednisone [routes and time to reactions onsets not stated; not all indications, dosages and outcomes stated].

Patient K.S.: A 46-year-old woman developed osteoporosis and complications like kyphosis, breathing and gastrointestinal problems related to spinal deformity, vertebral fractures L1 and 4, vertebral pain syndrome and compression of the thoracic vertebrae following treatment with prednisone. Ten years prior, she had suffered a traumatic L1 fracture. In the beginning of 2016, she was diagnosed with immunogenic hyperthyroidism with thyroid...